Austin Angelo

About the Author Austin Angelo


Canaccord Genuity Thinks Laird Superfood’s Stock is Going to Recover

Canaccord Genuity analyst Robert Burleson maintained a Buy rating on Laird Superfood (LSF) yesterday and set a price target of $70.00.

Oppenheimer Believes Centene (CNC) Won’t Stop Here

Oppenheimer analyst Michael Wiederhorn assigned a Buy rating to Centene (CNC) today and set a price target of $90.00.

H.C. Wainwright Reiterates Their Buy Rating on Enlivex Therapeutics (ENLV)

In a report released today, Ram Selvaraju from H.C.

OncoCyte (OCX) Receives a Buy from Needham

In a report released today, Michael Matson from Needham assigned a Buy rating to OncoCyte (OCX), with a price target of $8.00.

Jefferies Sticks to Their Buy Rating for El Pollo LoCo (LOCO)

In a report issued on May 7, Andy Barish from Jefferies maintained a Buy rating on El Pollo LoCo (LOCO), with a price …

Mizuho Securities Maintains a Buy Rating on Nkarta (NKTX)

In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Nkarta (NKTX), with a price target of $81.00.

BTIG Maintains Their Buy Rating on OncoSec Medical (ONCS)

In a report issued on June 13, Thomas Shrader from BTIG maintained a Buy rating on OncoSec Medical (ONCS), with a price target …

Leerink Partners Remains a Hold on Acceleron Pharma (XLRN)

In a report issued on June 11, Geoff Porges from Leerink Partners maintained a Hold rating on Acceleron Pharma (XLRN). The company’s shares …

Bluebird Bio (BLUE) Receives a Hold from Oppenheimer

In a report released today, Mark Breidenbach from Oppenheimer assigned a Hold rating to Bluebird Bio (BLUE). The company’s shares closed last Monday …

Sierra Oncology (SRRA) Receives a Rating Update from a Top Analyst

In a report released today, Joseph Pantginis from H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts